4.8 Article

Orally administered Odoribacter laneus improves glucose control and inflammatory profile in obese mice by depleting circulating succinate

期刊

MICROBIOME
卷 10, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s40168-022-01306-y

关键词

Succinate; Obesity; Probiotics; Animal models; Inflammation; Glucose tolerance

资金

  1. MCIN/AEI [SAF2015-65019-R, RTI2018093919-B-100]
  2. ISCIII [PI20/00095, PI20/00338]
  3. ERDF A way of making Europe
  4. La Caixa Foundation [LCF/TR/CI19/52460004, LCF/PR/HR20-00051]
  5. Fundacion para la Innovacion y la Prospectiva en Salud en Espana (FIPSE) [2799-21]
  6. Instituto de Salud Carlos III [DTS19/00040]
  7. Agency for Management of University and Research Grants (AGAUR) [019 PROD 00107, 2019 INNOV 00008]
  8. Universitat Rovira I Virgili [R2B2019/11]
  9. University Secretariat and Research of the Department of Research and Universities of the Generalitat de Catalunya
  10. European Regional Development Fund (ERDF)
  11. Spanish Biomedical Research Center in Diabetes and Associated Metabolic Disorders (CIBERDEM) [CB07708/0012]

向作者/读者索取更多资源

The study reveals that gut microbiota is a significant source of elevated succinate in obese individuals. Therapeutic treatments with selected bacteria can reduce circulating succinate levels in obese mice, and Odoribacter laneus shows promise as a probiotic to deplete succinate and improve glucose tolerance.
Background: Succinate is produced by both human cells and by gut bacteria and couples metabolism to inflammation as an extracellular signaling transducer. Circulating succinate is elevated in patients with obesity and type 2 diabetes and is linked to numerous complications, yet no studies have specifically addressed the contribution of gut microbiota to systemic succinate or explored the consequences of reducing intestinal succinate levels in this setting. Results: Using germ-free and microbiota-depleted mouse models, we show that the gut microbiota is a significant source of circulating succinate, which is elevated in obesity. We also show in vivo that therapeutic treatments with selected bacteria diminish the levels of circulating succinate in obese mice. Specifically, we demonstrate that Odoribacter laneus is a promising probiotic based on its ability to deplete succinate and improve glucose tolerance and the inflammatory profile in two independent models of obesity (db/db mice and diet-induced obese mice). Mechanistically, this is partly mediated by the succinate receptor 1. Supporting these preclinical findings, we demonstrate an inverse correlation between plasma and fecal levels of succinate in a cohort of patients with severe obesity. We also show that plasma succinate, which is associated with several components of metabolic syndrome including waist circumference, triglycerides, and uric acid, among others, is a primary determinant of insulin sensitivity evaluated by the euglycemic-hyperinsulinemic clamp. Conclusions: Overall, our work uncovers O. laneus as a promising next-generation probiotic to deplete succinate and improve glucose tolerance and obesity-related inflammation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据